Gilead Sciences, Inc. (BIT:1GILD)
Italy · Delayed Price · Currency is EUR 131.38
+5.32 (4.22%)
At close: Feb 11, 2026
Gilead Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 29,442 | 28,754 | 27,116 | 27,281 | 27,305 |
Other Revenue | 1 | - | - | - | - |
| 29,443 | 28,754 | 27,116 | 27,281 | 27,305 | |
Revenue Growth (YoY) | 2.40% | 6.04% | -0.60% | -0.09% | 10.60% |
Cost of Revenue | 6,230 | 6,251 | 6,019 | 5,657 | 5,526 |
Gross Profit | 23,213 | 22,503 | 21,097 | 21,624 | 21,779 |
Selling, General & Admin | 5,709 | 6,000 | 6,062 | 5,673 | 5,246 |
Research & Development | 5,687 | 5,816 | 5,758 | 4,977 | 4,601 |
Operating Expenses | 11,396 | 11,816 | 11,820 | 10,650 | 9,847 |
Operating Income | 11,817 | 10,687 | 9,277 | 10,974 | 11,932 |
Interest Expense | -1,024 | -977 | -944 | -935 | -1,001 |
Interest & Investment Income | - | 281 | 376 | 106 | - |
Currency Exchange Gain (Loss) | - | 14 | -12 | - | -23 |
Other Non Operating Income (Expenses) | 347 | -15 | 2 | -30 | -6 |
EBT Excluding Unusual Items | 11,140 | 9,990 | 8,699 | 10,115 | 10,902 |
Merger & Restructuring Charges | -138 | -189 | -527 | - | - |
Gain (Loss) on Sale of Investments | 451 | -274 | -167 | -657 | -610 |
Legal Settlements | - | - | - | - | -1,075 |
Other Unusual Items | -43 | 7 | 60 | - | - |
Pretax Income | 9,796 | 691 | 6,860 | 5,814 | 8,278 |
Income Tax Expense | 1,286 | 211 | 1,247 | 1,248 | 2,077 |
Earnings From Continuing Operations | 8,510 | 480 | 5,613 | 4,566 | 6,201 |
Minority Interest in Earnings | - | - | 52 | 26 | 24 |
Net Income | 8,510 | 480 | 5,665 | 4,592 | 6,225 |
Net Income to Common | 8,510 | 480 | 5,665 | 4,592 | 6,225 |
Net Income Growth | 1672.92% | -91.53% | 23.37% | -26.23% | 4960.98% |
Shares Outstanding (Basic) | 1,244 | 1,247 | 1,248 | 1,255 | 1,256 |
Shares Outstanding (Diluted) | 1,255 | 1,255 | 1,258 | 1,262 | 1,262 |
Shares Change (YoY) | - | -0.24% | -0.32% | - | -0.08% |
EPS (Basic) | 6.84 | 0.38 | 4.54 | 3.66 | 4.96 |
EPS (Diluted) | 6.78 | 0.38 | 4.50 | 3.64 | 4.93 |
EPS Growth | 1684.21% | -91.56% | 23.63% | -26.17% | 4938.22% |
Free Cash Flow | 9,456 | 10,305 | 7,421 | 8,344 | 10,805 |
Free Cash Flow Per Share | 7.54 | 8.21 | 5.90 | 6.61 | 8.56 |
Dividend Per Share | 3.160 | 3.080 | 3.000 | 2.920 | 2.840 |
Dividend Growth | 2.60% | 2.67% | 2.74% | 2.82% | 4.41% |
Gross Margin | 78.84% | 78.26% | 77.80% | 79.26% | 79.76% |
Operating Margin | 40.13% | 37.17% | 34.21% | 40.23% | 43.70% |
Profit Margin | 28.90% | 1.67% | 20.89% | 16.83% | 22.80% |
Free Cash Flow Margin | 32.12% | 35.84% | 27.37% | 30.59% | 39.57% |
EBITDA | 14,581 | 13,454 | 11,970 | 13,077 | 13,982 |
EBITDA Margin | 49.52% | 46.79% | 44.14% | 47.93% | 51.21% |
D&A For EBITDA | 2,764 | 2,767 | 2,693 | 2,103 | 2,050 |
EBIT | 11,817 | 10,687 | 9,277 | 10,974 | 11,932 |
EBIT Margin | 40.13% | 37.17% | 34.21% | 40.23% | 43.70% |
Effective Tax Rate | 13.13% | 30.54% | 18.18% | 21.46% | 25.09% |
Revenue as Reported | 29,443 | 28,754 | 27,116 | 27,281 | 27,305 |
Advertising Expenses | - | 869 | 826 | 778 | 735 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.